SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001564590-20-038927
Filing Date
2020-08-10
Accepted
2020-08-10 16:11:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A mirm-s3a.htm S-3/A 626538
2 EX-23.1 mirm-ex231_7.htm EX-23.1 3176
4 GRAPHIC gu23kvltwqnj000003.jpg GRAPHIC 5430
5 GRAPHIC gu23kvltwqnj000002.jpg GRAPHIC 4835
6 GRAPHIC gu23kvltwqnj000001.jpg GRAPHIC 4835
7 filename7.htm CORRESP 7646
  Complete submission text file 0001564590-20-038927.txt   659646
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-240290 | Film No.: 201089476
SIC: 2834 Pharmaceutical Preparations